Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Praxis Precision Medicines

Biotech & Life Sciences · Cambridge, United States · Founded 2015 · IPO 2020 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$8.37B
Market cap · Apr/2026

Investors

13 investors on Praxis Precision Medicines's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 13 investors entered at this stage
Adage Capital
Cormorant Asset Management
Point72 Ventures
Verition Fund Management
Citadel
Irving Investors
Novo Holdings
OCV Partners
Eventide Asset Management
Avoro Capital Advisors
Qatar Investment Authority
Blackstone
Vida Ventures

Global footprint

Where Praxis Precision Medicines has talent and traffic

Web traffic by country
12K monthly visits
across markets
🇺🇸 United States65%
🏳️ Korea15.8%
🏳️ Republic of8.3%
🇮🇳 India4.2%
🇪🇸 Spain3.3%
Top 5 markets shown

See Praxis Precision Medicines on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo